ArticleBioengineered2021

High expression of ladinin-1 (LAD1) predicts adverse outcomes: a new candidate docetaxel resistance gene for prostatic cancer (PCa).

Jianping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.